Clinical Trial Update: JP-1730 to Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of JP-1730 for Parkinson's disease has completed, as noted in the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• JP-1730

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED